| 2024 |
| 04/23 | 2,217 | 2,248 | 2,215 | 2,239 | +0.77% | 28,800 | 684億3100万 | +1.77% |
| 04/22 | 2,240 | 2,240 | 2,207 | 2,222 | +0.68% | 22,100 | 679億1142万 | +1.23% |
| 04/19 | 2,244 | 2,244 | 2,164 | 2,207 | -2% | 85,500 | 674億5298万 | +0.73% |
| 04/18 | 2,220 | 2,273 | 2,203 | 2,252 | +2.41% | 40,000 | 688億2832万 | +2.97% |
| 04/17 | 2,275 | 2,275 | 2,163 | 2,199 | -2.83% | 59,300 | 672億847万 | +0.73% |
| 04/16 | 2,283 | 2,313 | 2,249 | 2,263 | -0.96% | 64,000 | 691億6451万 | +3.81% |
| 04/15 | 2,250 | 2,292 | 2,223 | 2,285 | +1.11% | 52,400 | 698億3690万 | +5.06% |
| 04/12 | 2,210 | 2,281 | 2,208 | 2,260 | +3.06% | 85,600 | 690億7282万 | +4.2% |
| 04/11 | （IR情報）15:00 LF111国内第III相臨床試験における主要評価項目達成に関するお知らせ |
| 04/11 | 2,177 | 2,197 | 2,174 | 2,193 | -0.32% | 43,600 | 670億2509万 | +1.48% |
| 04/10 | 2,166 | 2,201 | 2,165 | 2,200 | +1.95% | 29,300 | 672億3903万 | +2.09% |
| 04/09 | 2,198 | 2,201 | 2,145 | 2,158 | -1.1% | 48,400 | 659億5538万 | +0.51% |
| 04/08 | 2,199 | 2,199 | 2,160 | 2,182 | -1.36% | 77,000 | 666億8890万 | +1.87% |
| 04/05 | 2,174 | 2,219 | 2,174 | 2,212 | +1.89% | 45,500 | 676億579万 | +3.56% |
| 04/04 | （5%ルール）エヌエーブイエフ・セレクト・エルエルシー(NAVF …（1.48%）ダルトン・インベストメンツ・インク(Dalton Inve…（0.9%）ニッポン・アクティブ・バリュー・ファンド(NIPPO…（4.16%） |
| 04/04 | 2,172 | 2,183 | 2,159 | 2,171 | +0.05% | 56,000 | 663億5270万 | +1.88% |
| 04/03 | 2,194 | 2,194 | 2,145 | 2,170 | -1.09% | 82,200 | 663億2214万 | +1.97% |
| 04/02 | 2,193 | 2,229 | 2,177 | 2,194 | +1.57% | 101,500 | 670億5565万 | +3.34% |
| 04/02 | （空売り報告）Diversified Select Opportunities Capital Manag… 157,000株（0.51%）新規 |
| 04/01 | （IR情報）15:00 就任、組織改正および人事異動のお知らせ |
| 04/01 | （IR情報）15:00 「ワークサポート応援金」創設と従業員に対するがん保険加入のお知らせ |
| 04/01 | 2,200 | 2,207 | 2,150 | 2,160 | -2.66% | 71,600 | 660億1650万 | +1.98% |
| 03/29 | 2,202 | 2,244 | 2,195 | 2,219 | +0.41% | 42,900 | 678億1973万 | +4.97% |
| 03/28 | 2,223 | 2,227 | 2,191 | 2,210 | -1.47% | 42,200 | 675億4466万 | +4.89% |
| 03/27 | 2,231 | 2,259 | 2,219 | 2,243 | +0.58% | 84,700 | 685億5325万 | +6.76% |
| 03/26 | （IR情報）15:00 難吸収性リファマイシン系抗菌薬「リフキシマ錠（リファキシミン）」の小児に対する用法及び用量の追加に係る製造販売承認事項一部変更承認取得のお知らせ |
| 03/26 | 2,149 | 2,233 | 2,145 | 2,230 | +4.94% | 89,000 | 681億5593万 | +6.55% |
| 03/25 | 2,120 | 2,142 | 2,112 | 2,125 | 0% | 35,500 | 649億4679万 | +2.07% |
| 03/22 | 2,144 | 2,147 | 2,120 | 2,125 | -0.89% | 28,800 | 649億4679万 | +2.41% |
| 03/21 | 2,137 | 2,158 | 2,130 | 2,144 | +0.09% | 33,000 | 655億2749万 | +3.68% |
| 03/19 | 2,125 | 2,149 | 2,113 | 2,142 | +1.18% | 31,000 | 654億6637万 | +3.98% |
| 03/18 | （IR情報）15:00 Red Arrow Therapeuticsとあすか製薬、妊娠高血圧症候群の新規治療薬開発のための共同研究契約を締結 |
| 03/18 | 2,144 | 2,155 | 2,110 | 2,117 | -0.14% | 80,700 | 647億229万 | +3.12% |
| 03/15 | 2,107 | 2,134 | 2,091 | 2,120 | +0.76% | 56,200 | 647億9398万 | +3.67% |
| 03/14 | 2,142 | 2,158 | 2,090 | 2,104 | -1.77% | 66,800 | 643億497万 | +3.34% |
| 03/13 | 2,150 | 2,182 | 2,115 | 2,142 | +0.14% | 65,700 | 654億6637万 | +5.67% |
| 03/12 | 2,146 | 2,147 | 2,114 | 2,139 | +0.99% | 60,600 | 653億7468万 | +6% |
| 03/11 | 2,081 | 2,118 | 2,081 | 2,118 | -1.17% | 75,000 | 647億3285万 | +5.37% |
| 03/08 | 2,062 | 2,150 | 2,062 | 2,143 | +3.23% | 74,200 | 654億9693万 | +6.94% |
| 03/07 | 2,039 | 2,085 | 2,039 | 2,076 | +2.32% | 70,900 | 634億4920万 | +3.9% |
| 03/06 | 2,000 | 2,035 | 1,999 | 2,029 | +1.35% | 64,600 | 620億1273万 | +1.76% |
| 03/05 | 2,028 | 2,031 | 2,002 | 2,002 | -0.94% | 51,600 | 611億8752万 | +0.5% |
| 03/04 | 2,031 | 2,038 | 1,988 | 2,021 | -1.41% | 77,300 | 617億6822万 | +1.46% |
| 03/01 | 2,082 | 2,094 | 2,029 | 2,050 | -1.77% | 71,800 | 626億5455万 | +2.96% |
| 02/29 | 2,099 | 2,105 | 2,061 | 2,087 | -0.67% | 79,900 | 637億8539万 | +5.09% |
| 02/28 | 2,079 | 2,108 | 2,060 | 2,101 | +3.04% | 74,600 | 642億1328万 | +6.16% |
| 02/27 | 2,058 | 2,071 | 2,033 | 2,039 | -0.92% | 52,500 | 623億1836万 | +3.5% |
| 02/26 | 2,058 | 2,094 | 2,040 | 2,058 | 0% | 53,500 | 628億9906万 | +4.84% |
| 02/22 | 2,103 | 2,103 | 2,056 | 2,058 | -0.29% | 58,800 | 628億9906万 | +5.27% |
| 02/21 | 2,100 | 2,111 | 2,055 | 2,064 | +0.63% | 75,000 | 630億8244万 | +6.01% |
| 02/20 | 2,040 | 2,071 | 2,024 | 2,051 | +0.29% | 68,900 | 626億8512万 | +5.78% |
| 02/19 | 1,950 | 2,048 | 1,950 | 2,045 | +4.23% | 106,500 | 625億174万 | +5.9% |
| 02/16 | 1,940 | 1,970 | 1,940 | 1,962 | +1.55% | 56,300 | 599億6499万 | +2.08% |
| 02/15 | 1,960 | 1,960 | 1,917 | 1,932 | -1.02% | 66,000 | 590億4810万 | +0.78% |
| 02/14 | 1,955 | 1,959 | 1,946 | 1,952 | -0.15% | 43,900 | 596億5936万 | +2.04% |
| 02/13 | 1,977 | 1,977 | 1,945 | 1,955 | +0.26% | 77,500 | 597億5105万 | +2.41% |
| 02/09 | 1,950 | 1,958 | 1,937 | 1,950 | +0.98% | 89,500 | 595億9823万 | +2.42% |
| 02/08 | 1,905 | 1,946 | 1,896 | 1,931 | +1.52% | 91,500 | 590億1753万 | +1.74% |
| 02/07 | 1,863 | 1,910 | 1,849 | 1,902 | +1.82% | 95,100 | 581億3120万 | +0.53% |
| 02/06 | 1,910 | 1,910 | 1,840 | 1,868 | -2.35% | 186,000 | 570億9205万 | -1.01% |
| 02/05 | （IR情報）15:00 2024年3月期第3四半期決算短信補足資料 |
| 02/05 | （IR情報）15:00 2024年3月期第3四半期決算短信〔日本基準〕(連結) |
| 02/05 | 1,953 | 1,953 | 1,910 | 1,913 | -1.03% | 106,700 | 584億6739万 | +1.59% |
| 02/02 | 1,969 | 1,969 | 1,918 | 1,933 | -2.32% | 114,700 | 590億7866万 | +2.98% |
| 02/01 | 1,980 | 1,995 | 1,972 | 1,979 | -0.25% | 86,800 | 604億8457万 | +5.77% |
| 01/31 | 1,973 | 1,993 | 1,958 | 1,984 | +0.46% | 53,500 | 606億3738万 | +6.61% |
| 01/30 | 1,986 | 1,990 | 1,950 | 1,975 | -1.05% | 69,600 | 603億6231万 | +6.7% |
| 01/29 | 2,000 | 2,024 | 1,979 | 1,996 | +0.4% | 76,700 | 610億414万 | +8.42% |
| 01/26 | 2,001 | 2,002 | 1,971 | 1,988 | -0.25% | 86,700 | 607億5963万 | +8.57% |
| 01/25 | 1,959 | 2,000 | 1,957 | 1,993 | +2.68% | 136,900 | 609億1245万 | +9.45% |
| 01/24 | 1,907 | 1,954 | 1,907 | 1,941 | +1.89% | 79,300 | 593億2316万 | +7.18% |
| 01/23 | 1,885 | 1,917 | 1,880 | 1,905 | +1.28% | 70,600 | 582億2289万 | +5.54% |
| 01/22 | 1,852 | 1,882 | 1,850 | 1,881 | +1.84% | 36,700 | 574億8937万 | +4.5% |
| 01/19 | 1,872 | 1,872 | 1,839 | 1,847 | -1.44% | 38,300 | 564億5022万 | +2.84% |
| 01/18 | 1,850 | 1,878 | 1,850 | 1,874 | +1.41% | 66,900 | 572億7543万 | +4.52% |
| 01/17 | 1,861 | 1,879 | 1,847 | 1,848 | -0.7% | 79,400 | 564億8079万 | +3.36% |
| 01/16 | 1,850 | 1,876 | 1,850 | 1,861 | +0.59% | 49,500 | 568億7811万 | +4.26% |
| 01/15 | 1,831 | 1,855 | 1,825 | 1,850 | +0.82% | 82,400 | 565億4191万 | +3.82% |
| 01/12 | 1,904 | 1,904 | 1,828 | 1,835 | +0.6% | 122,700 | 560億8347万 | +3.09% |
| 01/11 | （5%ルール）エヌエーブイエフ・セレクト・エルエルシー(NAVF …（1.38%）ダルトン・インベストメンツ・インク(Dalton Inve…（0.52%）ダルトン・インベストメンツ・エルエルシー(Dalto…（0%）ニッポン・アクティブ・バリュー・ファンド(NIPPO…（3.63%） |
| 01/11 | 1,856 | 1,863 | 1,812 | 1,824 | -1.46% | 85,700 | 557億4727万 | +2.53% |
| 01/10 | 1,821 | 1,860 | 1,821 | 1,851 | +0.87% | 67,300 | 565億7248万 | +4.05% |
| 01/09 | 1,833 | 1,838 | 1,821 | 1,835 | +0.55% | 53,300 | 560億8347万 | +3.21% |
| 01/05 | 1,820 | 1,845 | 1,820 | 1,825 | +0.61% | 33,900 | 557億7783万 | +2.7% |
| 01/04 | 1,800 | 1,819 | 1,787 | 1,814 | +1.68% | 52,300 | 554億4164万 | +2.14% |
| 2023 |
| 12/29 | 1,779 | 1,788 | 1,775 | 1,784 | +1.13% | 38,000 | 545億2474万 | +0.45% |
| 12/28 | 1,781 | 1,781 | 1,752 | 1,764 | -0.95% | 37,900 | 539億1348万 | -0.73% |
| 12/27 | 1,765 | 1,784 | 1,762 | 1,781 | +0.68% | 64,300 | 544億3305万 | +0.17% |
| 12/26 | 1,768 | 1,777 | 1,760 | 1,769 | +0.06% | 44,400 | 540億6629万 | -0.51% |
| 12/25 | 1,782 | 1,790 | 1,756 | 1,768 | +1.49% | 50,700 | 540億3573万 | -0.56% |
| 12/22 | 1,715 | 1,745 | 1,714 | 1,742 | +1.57% | 37,400 | 532億4109万 | -2.13% |
| 12/21 | 1,721 | 1,723 | 1,712 | 1,715 | -1.66% | 46,000 | 524億1588万 | -3.71% |
| 12/20 | 1,733 | 1,748 | 1,733 | 1,744 | +0.29% | 46,900 | 533億221万 | -2.3% |
| 12/19 | 1,730 | 1,739 | 1,716 | 1,739 | +0.52% | 45,300 | 531億4940万 | -2.69% |
| 12/18 | 1,740 | 1,740 | 1,718 | 1,730 | -0.8% | 37,300 | 528億7433万 | -3.46% |
| 12/15 | 1,772 | 1,774 | 1,716 | 1,744 | -2.57% | 90,200 | 533億221万 | -2.95% |
| 12/14 | 1,807 | 1,810 | 1,780 | 1,790 | +0.11% | 59,800 | 547億812万 | -0.56% |
| 12/13 | 1,773 | 1,790 | 1,766 | 1,788 | +0.79% | 39,100 | 546億4699万 | -0.67% |
| 12/12 | 1,777 | 1,780 | 1,765 | 1,774 | -0.17% | 40,300 | 542億1911万 | -1.77% |
| 12/11 | 1,756 | 1,779 | 1,752 | 1,777 | +1.08% | 37,000 | 543億1080万 | -1.44% |
| 12/08 | 1,784 | 1,784 | 1,749 | 1,758 | -0.45% | 62,200 | 537億3010万 | -2.39% |
| 12/07 | 1,779 | 1,795 | 1,763 | 1,766 | -1.51% | 41,300 | 539億7460万 | -1.78% |
| 12/06 | 1,784 | 1,801 | 1,784 | 1,793 | -0.17% | 47,800 | 547億9981万 | -0.17% |
| 12/05 | 1,800 | 1,821 | 1,796 | 1,796 | -0.28% | 55,500 | 548億9150万 | +0.22% |
| 12/04 | 1,825 | 1,825 | 1,788 | 1,801 | -1.75% | 67,300 | 550億4432万 | +0.73% |
| 12/01 | 1,821 | 1,849 | 1,812 | 1,833 | +0.66% | 60,000 | 560億2234万 | +2.75% |
| 11/30 | 1,790 | 1,826 | 1,782 | 1,821 | +1.17% | 46,500 | 556億5558万 | +2.42% |
| 11/29 | 1,831 | 1,835 | 1,800 | 1,800 | -1.15% | 64,200 | 550億1375万 | +1.52% |
| 11/28 | 1,829 | 1,840 | 1,801 | 1,821 | +1.17% | 69,000 | 556億5558万 | +2.94% |
| 11/27 | 1,834 | 1,837 | 1,794 | 1,800 | 0% | 87,700 | 550億1375万 | +2.04% |
| 11/24 | （5%ルール）エヌエーブイエフ・セレクト・エルエルシー(NAVF …（1.22%）ダルトン・インベストメンツ・エルエルシー(Dalto…（1.07%）ニッポン・アクティブ・バリュー・ファンド(NIPPO…（2.8%） |
